Completed NA INTERVENTIONAL 1-arm NCT05592548

Rosacea Treatment Using Non-thermal (cold) Atmospheric Plasma Device

Open Label Split Face Pilot Study to Assess the Safety and Efficacy of Cold Atmospheric Plasma (non-thermal Plasma) for the Treatment of Rosacea

Sponsor: The Skin Center Dermatology Group

Conditions Rosacea, Papulopustular

Interventions cold atmospheric plasma

Updated 5 times since 2022 Last updated: Dec 1, 2024 Started: Jan 2, 2024 Primary completion: May 31, 2024 Completion: Jun 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05592548, this NA trial focuses on Rosacea, Papulopustular and remains completed. Sponsored by The Skin Center Dermatology Group, it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Jan 2025 — Present [monthly]

Completed NA

Status: Suspended → Completed
Sep 2024 — Jan 2025 [monthly]

Suspended NA
Jul 2024 — Sep 2024 [monthly]

Suspended NA
May 2023 — Jul 2024 [monthly]

Suspended NA

Status: Recruiting → Suspended
Nov 2022 — May 2023 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Skin Center Dermatology Group

Data source: The Skin Center Dermatology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New City, United States